Procedure
Repositioning
Repositioning is a medical procedure with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
The Effect of Repositioning Frequency Determined According to BMI on Pressure Ulcer Development Time
NCT05504980
terminatednot_applicable
POsitioning for Esophageal Cancer Resection
NCT02157363
completed
Pain Assessment in the Intensive Care Unit
NCT01628185
completedphase_3
Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens
NCT00847665
Clinical Trials (4)
Showing 4 of 4 trials
NCT05504980Not Applicable
The Effect of Repositioning Frequency Determined According to BMI on Pressure Ulcer Development Time
NCT02157363Not Applicable
POsitioning for Esophageal Cancer Resection
NCT01628185
Pain Assessment in the Intensive Care Unit
NCT00847665Phase 3
Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4